Actively Recruiting
Opioid Dispenser for Microdiscectomy/Laminectomy
Led by Hospital for Special Surgery, New York · Updated on 2025-12-08
30
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The opioid crisis continues to plague the United States. While great strides have been made nationwide to decrease overprescribing, improvements are still needed to appropriately educate patients on the safe and responsible use, storage and disposal of opioids. Pain after surgery is often treated with opioid medications. Opioid medications can have side effects. Some side effects are relatively minor (constipation, nausea, vomiting), while others are more severe (sedation, abnormal breathing, etc.) and can lead to serious illness or death. Opioid pain medications when used the wrong way may also be addictive. Due to theses side effects, sometimes patients feel uncomfortable about taking these medications, and doctors prescribe them very cautiously. However, when used properly and safely, opioid pain medications are excellent pain relievers. Addinex, a technology company, has developed a device to help patients take opioids more safely. In this study the investigators aim to enroll a total of 30 patients who undergo spine surgery. Half will be randomly assigned to receive a standard pill bottle with opioids at discharge and will download a mobile app so that they can record their daily pain scores and the number of opioids they take for two weeks after surgery. The other half will receive the new opioid dispenser filled with opioids and a mobile app that generates a passcode that opens that device only at designated times. For this group of patients, every time the patient wants to take an opioid, they need to go to the app, enter their pain score before the app generates a passcode. The investigators will be tracking all study patients' opioid use and pain scores for the two weeks after surgery, will count how many pills they have left over 14 days after their surgery during a live telehealth session, and ask patients how they liked using the device. Results from this study will help understand if the Addinex device could potentially be useful to patients in the future after surgeries as opposed to typical pill bottles.
CONDITIONS
Official Title
Opioid Dispenser for Microdiscectomy/Laminectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Opioid-naive patients or intermittent opioid users within 3 months of scheduled surgery
- At least 18 years old
- Presenting for primary elective one-level lumbar laminectomy and/or discectomy via posterior approach with participating surgeon
- Planned discharge on day of surgery or 23 hour admission
- Planned discharge to home
You will not qualify if you...
- Patients with opioid tolerance
- Patients without a smartphone or without the ability to perform telehealth visits
- Patients unable to use the medication dispensing device
- Patients presenting for other surgeries or surgeries with combined anterior/lateral approaches
- Patient refusal to participate
- Allergy or intolerance to opioids
- Planned admission after surgery
- Planned discharge to nursing facility or skilled rehabilitation
- Planned use of or preference for opioid other than oxycodone
- Patients who are pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital for Special Surgery
New York, New York, United States, 10021
Actively Recruiting
Research Team
W
William Chan, MEng
CONTACT
A
Alexandra Sideris, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here